Combination therapies for chronic hepatitis B in the era of emerging novel drugs Dandan Weng, Chenxi Zhang, Qunyan Wei, Lukan Zhang, Xinya Zang, Guancheng Huang, Zhujun Cao, Qing Xie Hepatology International.2026; 20(1): 9. CrossRef
Chimeric antigen receptor T‑cell therapy in chronic viral infections: a review Qiyang Han, Xiaoying Zhang, Liting Chen, Yicheng Zhang Journal of Translational Medicine.2026;[Epub] CrossRef
AFP-specific T cell receptors with fine-tuning affinity induce durable tumor remission in mice and acquire pan-HLA-A∗02 recognition Chen-Song Huang, Jiajia Du, Jun Li, Ya-Hao Guo, Qingjia Yan, Shifan Wu, Xihe Chen, Tein Foong Leong, Si-Yun Chen, An-Da Zheng, Shudan Ou, Minjun Ma, Chunguang Yang, Lulu Zhang, Xiangjun Zhou, Junjun Chu, Yanyan Han Molecular Therapy.2026; 34(5): 2666. CrossRef
Exploiting the immunopathogenesis of hepatitis D virus infection to develop superior treatment options Rahaf Albarghash, Carina Jacobsen, Helenie Kefalakes Antiviral Research.2026; 250: 106416. CrossRef
Modular delivery of co-stimulatory signals through a PD-1-based immunoswitch receptor improves the functionality of Hepatitis B Virus-specific engineered T cells Luis Felipe Olguín-Contreras, Johanna Heep, Lisa Schiller, Eva Loffredo-Verde, Marvin M. Festag, Kai Metzger, Stephanie Färber, Merve Gültan, Margaret Tulessin, Susanne Wilde, Karin Wisskirchen, Elfriede Noessner, Ulrike Protzer Frontiers in Immunology.2026;[Epub] CrossRef
Virus infections and cancers: from mechanisms to therapeutics Yu Li, Wenjie Yu, Jiaxin Yun, Jingqian Wang, Yakun Liu, Huancheng Su, Hongrui Guo, Jiaolin Yang, Yaru Yan, Xiaoliang Yan, Sanyuan Zhang, Hailan Yang, Zhe Wang Molecular Biomedicine.2026;[Epub] CrossRef
Reply to correspondence on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting” Antonio Bertoletti, Anthony T Tan Clinical and Molecular Hepatology.2025; 31(1): e113. CrossRef
Correspondence to editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting” Shunda Du, Karin Wisskirchen, Ke Zhang, Ulrike Protzer Clinical and Molecular Hepatology.2025; 31(1): e44. CrossRef
Viral oncogenesis in cancer: from mechanisms to therapeutics Qing Xiao, Yi Liu, Tingting Li, Chaoyu Wang, Sanxiu He, Liuyue Zhai, Zailin Yang, Xiaomei Zhang, Yongzhong Wu, Yao Liu Signal Transduction and Targeted Therapy.2025;[Epub] CrossRef
M1‐Like Macrophage May Contribute to the Inflammation and Fibrosis Process of Chronic Hepatitis B Yuxue Gao, Pengxiang Yang, Yuanyue Guan, Pengxiang Liu, Dexi Chen, Qiqi Ning Journal of Viral Hepatitis.2025;[Epub] CrossRef
Viral oncogenesis and immune remodeling: Decoding the therapeutic potential of immune checkpoint inhibitors in virus-associated cancers Lihua Qi, Bai Hu, Canhui Cao, Ting Peng, Miaochun Xu, Shiyi Liu, Yashi Xu, Xiaojie Liu, Wencheng Ding, Li Li, Shitong Lin Biomedicine & Pharmacotherapy.2025; 191: 118515. CrossRef
T cells engineered to carry a high-affinity HBV-specific T cell receptor: a potent weapon against advanced HBV-related HCC Robert Thimme, Christoph Neumann-Haefelin Gut.2025; : gutjnl-2025-336452. CrossRef
Adoptive T-cell therapy for virus-associated diseases Corey Smith, Rajiv Khanna, Graeme N. Forrest Clinical Microbiology Reviews.2025;[Epub] CrossRef
HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation Qiang Zhao, Jinbo Huang, Weixin Luo, Haidong Tan, Regina Wan Ju Wong, Zhiying Liu, Meiting Qin, Jiahao Li, Sarene Koh, Lu-En Wai, Tingting Wang, Jia Dan, Zhiyong Guo, Xiaoshun He Clinical Cancer Research.2025; 31(18): 3886. CrossRef
HBV antigen as a tumour antigen in adoptive TCR-T cell therapy for HBV-related HCC: rationale and clinical effectiveness Shan He, Anthony T. Tan, Antonio Bertoletti Seminars in Immunology.2025; 80: 102004. CrossRef
First
Prev
